Patient Engagement Solutions Market

Patient Engagement Solutions Market by Component (Hardware (Tablet)), Software (Integrated), Therapy (CVD, Diabetes), Functionality (Education, Scheduling), User (Provider, Payer (Public)), Unmet Need, Investment, Buying Criteria - Global Forecast to 2028

Report Code: HIT 2767 Dec, 2023, by marketsandmarkets.com

The global patient engagement solutions market in terms of revenue was estimated to be worth $22.5 billion in 2023 and is poised to reach $41.8 billion by 2028, growing at a CAGR of 13.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Factors such as the implementation of government regulations and initiatives to encourage patient-centric care, the growing demand for patient engagement solutions, the increasing number of collaborations and partnerships between stakeholders, and the rising use of mobile health apps are the factors driving the growth of this market.

However, large investment requirements for healthcare infrastructure, inadequate interoperability across healthcare providers, and a dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.

Global Patient Engagement Solutions Market Trend

Patient Engagement Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

Patient Engagement Solutions Market

Patient Engagement Solutions Market Dynamics

Driver: Implementation of government regulations and initiatives to promote patient-centric care

In recent years, the implementation of government initiatives and regulations to promote patient-centric care has become a driving force in advancing the patient engagement solutions market. Governments worldwide have increasingly acknowledged the pivotal role of patient involvement in healthcare decision-making and overall outcomes. For instance, in the United States, the Centers for Medicare & Medicaid Services (CMS) launched the Promoting Interoperability program, which, since 2020, incentivizes healthcare providers to adopt electronic health records (EHRs) that enhance patient engagement. This initiative reflects a commitment to empowering patients by improving access to their health information. Furthermore, regulatory frameworks such as the Health Insurance Portability and Accountability Act (HIPAA) in the U.S., spanning the years 2020 to 2022, emphasize patient privacy and security, fostering trust and promoting the adoption of secure patient engagement solutions. Globally, initiatives like the European Commission's Digital Single Market strategy, ongoing throughout these years, aim to create a seamless digital healthcare experience for patients across European member states. These recent initiatives underscore a sustained effort to drive patient-centric care through the widespread adoption of advanced patient engagement solutions.

Restraint: Inadequate interoperability across healthcare providers

The lack of interoperability across healthcare providers is a barrier to advancing patient engagement. Confronted with poor interoperability, hospitals classically build or license interfaces to import and export information from internal and external sources, such as the hospital’s EHR, medical devices, laboratories, admit/discharge/transfer processes, and outside laboratories. Thus, a separate hospital may employ a few dozen interfaces, while a greater health system with several sites may have to hire hundreds or even thousands of interfaces. For care coordination models, far more complex interfaces will be important to accommodate data exchange. These interfaces prove costly and hard to maintain and demand highly skilled technicians for their effective operation. The health information exchanges employed by hospitals as a solution to interoperability barriers also pose several challenges involving capital-intensive operation and technical problems in their management.

Opportunity: Growth opportunities in emerging markets

Government initiatives promoting the adoption of Healthcare Information Technology (HCIT) solutions, increasing government expenditure on healthcare facilities, and the availability of skilled IT experts in emerging Asian countries, such as India and China, are anticipated to bolster the growth of the patient engagement solutions market in the Asia Pacific region. Technological advancements play a crucial role in reshaping the healthcare management sector of these countries.

Challenge: High deployment costs of healthcare IT systems

The high deployment cost of healthcare IT systems poses an important challenge to the industry. Implementing robust healthcare IT solutions demands substantial financial investment, encompassing software, hardware, infrastructure, and ongoing maintenance expenses. For healthcare providers, especially those operating on limited budgets, the upfront costs associated with acquiring and integrating sophisticated IT systems can be prohibitive. Additionally, the expenses related to staff training, data migration, and system customization contribute to the overall deployment cost burden. This challenge can impede the widespread adoption of advanced healthcare IT solutions, limiting their accessibility to a broader range of healthcare organizations. Addressing this challenge requires strategic planning, innovative financing models, and collaborative efforts to make cutting-edge healthcare IT systems more financially viable for healthcare providers of all sizes.

Patient Engagement Solutions Market Ecosystem

The patient engagement solutions market ecosystem comprises entities responsible for delivering these solutions to end users. The demand continues to grow and expand as healthcare providers and payers implement these solutions to optimize workload, improve data transfer, and focus on patient-centric care. Solution and service providers continue to enhance and mature their offerings to increase value addition.

The services offered consist of support & maintenance, upgradation, and managed services. The end users are mainly healthcare providers, payers, and patients.

Patient Engagement Solutions Market Ecosystem

By component, the software segment accounted for the largest share of the global patient engagement solutions industry in 2022.

Based on components, the patient engagement solutions market is bifurcated into software, hardware, and services. In 2022, the software segment accounted for the largest share of the global patient engagement solutions market by component. The hardware market is further segmented into integrated bedside terminals/assisted devices, in-room televisions, and tablets. The software market is further bifurcated into integrated software and standalone software. In 2023, the integrated software segment is expected to account for the largest share & this segment is also expected to grow at the highest CAGR during the forecast period. Integrated solutions help reduce the time spent manually entering data into a computer, thus enabling clinicians and administrative staff to spend more time with patients. Also, these solutions allow a user to complete multiple business functions from within the same interface.

By delivery mode, the on-premise solutions segment accounted for the largest share of the global patient engagement solutions industry.

Segmented by delivery mode, the patient engagement solutions market is categorized into on-premise and cloud-based/web-based modes. As of 2022, the on-premise mode segment secured the majority share in the global patient engagement solutions market. However, expectations indicate that the cloud-based/web-based mode segment is poised to achieve the most substantial CAGR throughout the forecast period. Factors such as scalability, flexibility, and affordability provided by cloud-based solutions support its growth in the patient engagement solutions market. These solutions also ease the limited costs incurred in the purchase of hardware and the licensing of software.

By application, the health management segment accounted for a considerable share in the patient engagement solutions industry in 2022.

Based on application, the patient engagement solutions market is bifurcated into health management, home health management, social & behavioral management, and financial health management. In 2022, the health management applications segment accounted for the largest share of the global patient engagement solutions market by application. Health management comprises a wide range of patient engagement tools that help patients engage with their providers and take initiatives to improve or maintain their health status and increased awareness among patients about health conditions are the factors driving market growth.

By region, North America accounted for the largest share of the global patient engagement solutions industry in 2022.

In 2022, North America accounted for the largest share of the global patient engagement solutions market by region. Favorable government initiatives and regulations, the need to curb healthcare costs, and the rising prevalence of chronic diseases are key factors driving market growth in the region. Several key players in the patient engagement solutions market are based in the US. This factor is also expected to contribute to the large share of North America in the global market.

Patient Engagement Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in patient engagement solutions market are McKesson Corporation (US), Veradigm (US), Oracle Corporation (US), Merative (US), Epic Systems Corporation (US), Orion Health (New Zealand), GetWellNetwork (US), athenahealth (US), Oneview Healthcare (Ireland), MEDITECH (US), IQVIA (US), Get Real Health (US), Cognizant (US), Harris Healthcare (US), Kareo (US), CureMD Healthcare (US), eClinicalWorks (US), and Lincor Solutions (US), AdvancedMD (US), Luma Health Inc. (US), WellStack(US), Vivify Health (US), Medhost (US), MEDISYSINC (US), and Patient point LLC (US). These players are increasingly focusing on new product launches and partnerships to expand their product offerings in the patient engagement solutions market.

Scope of the Patient Engagement Solutions Industry

Report Metric

Details

Market Revenue in 2023

$22.5 billion

Projected Revenue by 2028

$41.8 billion

Revenue Rate

Poised to Grow at a CAGR of 13.2%

Market Driver

Implementation of government regulations and initiatives to promote patient-centric care

Market Opportunity

Growth opportunities in emerging markets

The study categorizes the Patient engagement solutions market to forecast revenue and analyze trends in each of the following submarkets:

By component

  • Hardware
    • In-room televisions
    • Integrated bedside terminals/Assisted devices
    • Tablets
  • Software
    • Standalone Software
    • Integrated Software
  • Services

By Delivery Mode

  • On-Premise Mode
  • Cloud-Based Mode

By Application

  • Health management
  • Home health management
  • Social & behavioral management
  • Financial health management

By Therapeutic area

  • Chronic diseases
    • Cardiovascular diseases (CVD)
    • Diabetes
    • Obesity
  • Other chronic diseases
  • Women’s health
  • Fitness
  • Other Therapeutic Areas

By Functionality

  • Introduction
  • E-Prescribing
  • Telehealth
  • Patient/Client Scheduling
  • Document Management
  • Patient Education
  • Billing & Payments
  • Others Functionality

By End user

  • Providers
    • Hospitals and healthcare system
    • Ambulatory care centers
    • Home healthcare
  • Payers
    • Private
    • Public
  • Patients
  • Other End users

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • Rest of Middle East & Africa

Recent Developments of Patient Engagement Solutions Industry

  • In June 2022, Francisco Partners (US), a leading global investment firm that specializes in partnering with technology businesses, completed the acquisition of healthcare data and analytics assets that were chunk of IBM Watson Health. Under the ownership of Francisco Partners, the new standalone company has been called Merative. The company combines market-leading products that deliver value across the global healthcare ecosystem, serving clients in life sciences, imaging, health plans, and government health & human service sectors.
  • In 2021, McKesson (US) announced a strategic agreement with Merck (US) that provided the two healthcare leaders to connect the power of real-world evidence (RWE) regarding the common goal of enhancing patient outcomes and the quality of cancer care.
  • In 2021, Humana (US) collaborated with Merative (US) to install Merative Watson Assistant for Health Benefits; it is an AI-enabled virtual agent built in the Cloud. This agent helps offer a beneficial member experience while supporting greater clarity and transparency on benefits and other related matters for Humana Employer Group members.
  • In 2021, Allied Digestive Health (ADH) selected Athenahealth’s (US) cloud-based healthcare payments and patient engagement solutions to direct patient relations and revenue cycle excellence, thus maintaining the organization’s growth in the coming years.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 64)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 PATIENT ENGAGEMENT SOLUTIONS MARKET: INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE 
           1.3.1 MARKETS COVERED
           1.3.2 REGIONAL SEGMENTATION
           1.3.3 YEARS CONSIDERED
    1.4 CURRENCY CONSIDERED 
    1.5 STAKEHOLDERS 
    1.6 SUMMARY OF CHANGES 
    1.7 RECESSION IMPACT 
 
2 RESEARCH METHODOLOGY (Page No. - 70)
    2.1 RESEARCH DATA 
          FIGURE 1 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
           2.1.3 PRIMARY SOURCES
           2.1.4 KEY DATA FROM PRIMARY SOURCES
           2.1.5 KEY INDUSTRY INSIGHTS
                    FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION METHODOLOGY 
          FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    2.3 MARKET ESTIMATION 
           2.3.1 RESEARCH METHODOLOGY: MARKET ESTIMATION
           2.3.2 APPROACH: END USER-BASED MARKET ESTIMATION
                    FIGURE 4 RESEARCH METHODOLOGY: MARKET ESTIMATION
           2.3.3 TOP-DOWN APPROACH: CONTRIBUTION-BASED MARKET SIZE ESTIMATION
           2.3.4 TOP-DOWN APPROACH
           2.3.5 BOTTOM-UP APPROACH
                    FIGURE 5 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2023–2028)
                    FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    2.4 MARKET DATA ESTIMATION AND TRIANGULATION 
          FIGURE 7 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS 
    2.6 LIMITATIONS 
           2.6.1 SCOPE-RELATED LIMITATIONS
           2.6.2 METHODOLOGY-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: PATIENT ENGAGEMENT SOLUTIONS MARKET
    2.8 PATIENT ENGAGEMENT SOLUTIONS MARKET: RECESSION IMPACT 
 
3 EXECUTIVE SUMMARY (Page No. - 85)
    FIGURE 8 SOFTWARE TO BE LARGEST SEGMENT DURING FORECAST PERIOD
    FIGURE 9 CLOUD-BASED/WEB-BASED MODE TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    FIGURE 10 HEALTH MANAGEMENT TO DOMINATE PATIENT ENGAGEMENT SOLUTIONS MARKET DURING FORECAST PERIOD
    FIGURE 11 PROVIDER TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD
    FIGURE 12 GEOGRAPHICAL SNAPSHOT OF PATIENT ENGAGEMENT SOLUTIONS MARKET
 
4 PREMIUM INSIGHTS (Page No. - 89)
    4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET 
          FIGURE 13 GOVERNMENT INITIATIVES FOR PATIENT-CENTRIC CARE TO DRIVE MARKET
    4.2 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE & COUNTRY (2022) 
          FIGURE 14 ON-PREMISE MODE ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2022
    4.3 PATIENT ENGAGEMENT SOLUTIONS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 
          FIGURE 15 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
    4.4 PATIENT ENGAGEMENT SOLUTIONS MARKET: REGIONAL MIX 
          FIGURE 16 ASIA PACIFIC MARKET TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.5 PATIENT ENGAGEMENT SOLUTIONS MARKET: DEVELOPED VS. EMERGING ECONOMIES 
          FIGURE 17 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 93)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 18 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN PATIENT ENGAGEMENT SOLUTIONS MARKET
           5.2.1 DRIVERS
                    5.2.1.1 Implementation of government regulations and initiatives to promote patient-centric care
                    5.2.1.2 Increasing adoption of patient engagement solutions
                    5.2.1.3 Rising number of collaborations and partnerships between stakeholders
                                TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2023
                    5.2.1.4 Increasing utilization of mobile health apps
                    5.2.1.5 Rising geriatric population and subsequent increase in prevalence of chronic diseases
                                FIGURE 19 GERIATRIC POPULATION, BY REGION, 2010–2030 (% OF TOTAL POPULATION)
           5.2.2 RESTRAINTS
                    5.2.2.1 Large investment requirements for healthcare infrastructure
                    5.2.2.2 Protection of patient information
                                FIGURE 20 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES IN 2021
                    5.2.2.3 Inadequate interoperability across healthcare providers
                    5.2.2.4 Shortage of skilled IT professionals in healthcare industry
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growth opportunities in emerging markets
                    5.2.3.2 Wearable health technology
                    5.2.3.3 Cloud-computing solutions
           5.2.4 CHALLENGES
                    5.2.4.1 High deployment costs of healthcare IT systems
                    5.2.4.2 Low levels of healthcare literacy
    5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 
          FIGURE 21 REVENUE SHIFTS AND NEW REVENUE POCKETS FOR PATIENT ENGAGEMENT SOLUTIONS MARKET
    5.4 INDUSTRY TRENDS 
           5.4.1 AI-DRIVEN DIGITAL TRANSFORMATION TO DRIVE NEXT WAVE OF PATIENT ENGAGEMENT
           5.4.2 REAL-TIME REMOTE DIAGNOSIS TO BE INTEGRAL PART OF PATIENT ENGAGEMENT
           5.4.3 ROLE OF MHEALTH IN PATIENT ENGAGEMENT
           5.4.4 GROWING ADOPTION OF TELEMEDICINE
           5.4.5 RISE OF SMART HOSPITAL ROOMS AND BEDSIDE TABLETS
           5.4.6 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 22 PATIENT ENGAGEMENT SOLUTIONS MARKET: ECOSYSTEM ANALYSIS
    5.6 VALUE CHAIN ANALYSIS 
           5.6.1 RESEARCH AND DEVELOPMENT
           5.6.2 MATERIAL COMPONENTS
           5.6.3 MANUFACTURERS AND DEVELOPERS
           5.6.4 DISTRIBUTION AND SALES
           5.6.5 END-USER INDUSTRIES
           5.6.6 POST-SALE SERVICES
                    FIGURE 23 PATIENT ENGAGEMENT SOLUTIONS MARKET: VALUE CHAIN ANALYSIS
    5.7 TECHNOLOGY ANALYSIS 
           5.7.1 ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING (ML)
           5.7.2 VIRTUAL REALITY (VR) AND AUGMENTED REALITY (AR)
           5.7.3 REMOTE MONITORING DEVICES AND WEARABLES
    5.8 TARIFF AND REGULATORY ANALYSIS 
           5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.8.2 NORTH AMERICA
                    5.8.2.1 US
                               5.8.2.1.1 Health Insurance Portability and Accountability Act of 1996 (HIPAA)
                               5.8.2.1.2 Health Information Technology for Economic and Clinical Health Act of 2009 (HITECh)
                               5.8.2.1.3 Consumer Privacy Protection Act of 2017
                               5.8.2.1.4 Affordable Care Act, 2010
                    5.8.2.2 Canada
                               5.8.2.2.1 Personal Information Protection and Electronic Documents Act (PIPEDA)
           5.8.3 EUROPE
                    5.8.3.1 General Data Protection Regulation (GDPR), European Union (EU)
                    5.8.3.2 EU Cybersecurity Act
                    5.8.3.3 Germany
                               5.8.3.3.1 German Data Protection Act (Bundesdatenschutzgesetz, BDSG)
                    5.8.3.4 France
                               5.8.3.4.1 French Data Protection Act
                    5.8.3.5 Italy
                               5.8.3.5.1 Personal Data Protection Code (Legislative Decree 196/2003)
           5.8.4 ASIA PACIFIC
                    5.8.4.1 China
                               5.8.4.1.1 Cybersecurity Law of People’s Republic of China
                    5.8.4.2 Japan
                               5.8.4.2.1 Act on Protection of Personal Information (APPI)
                    5.8.4.3 India
                               5.8.4.3.1 The Information Technology Act, 2000
           5.8.5 LATIN AMERICA
                    5.8.5.1 Protection of Personal Information Act
           5.8.6 MIDDLE EAST & AFRICA
                    5.8.6.1 Private Cloud Computing Regulatory Framework
    5.9 PRICING ANALYSIS 
           5.9.1 PRICING OVERVIEW
                    FIGURE 24 PATIENT ENGAGEMENT SOLUTIONS MARKET: PRICING COMPONENTS
           5.9.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
                    FIGURE 25 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
                    TABLE 7 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
           5.9.3 INDICATIVE PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS
                    TABLE 8 INDICATIVE PRICING ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS
    5.10 TRADE ANALYSIS 
           FIGURE 26 EXPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022 (USD THOUSAND)
           FIGURE 27 IMPORT DATA FOR HS CODE 854231 FOR TOP COUNTRIES IN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022 (USD THOUSAND)
    5.11 PORTER’S FIVE FORCES ANALYSIS 
           TABLE 9 PATIENT ENGAGEMENT SOLUTIONS MARKET: PORTER’S FIVE FORCES ANALYSIS
           5.11.1 INTENSITY OF COMPETITIVE RIVALRY
           5.11.2 BARGAINING POWER OF SUPPLIERS
           5.11.3 BARGAINING POWER OF BUYERS
           5.11.4 THREAT OF NEW ENTRANTS
           5.11.5 THREAT OF SUBSTITUTES
    5.12 PATENT ANALYSIS 
           5.12.1 PATENT PUBLICATION TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS
                     FIGURE 28 PATENT PUBLICATION TRENDS (JANUARY 2012–NOVEMBER 2023)
           5.12.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
                     FIGURE 29 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR PATIENT ENGAGEMENT SOLUTIONS (JANUARY 2012–NOVEMBER 2023)
                     FIGURE 30 TOP APPLICANT COUNTRIES/REGIONS FOR PATIENT ENGAGEMENT SOLUTIONS PATENTS DOCUMENTS
                     TABLE 10 PATIENT ENGAGEMENT SOLUTIONS MARKET: LIST OF MAJOR PATENTS
    5.13 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.13.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PATIENT ENGAGEMENT SOLUTIONS
                     FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PATIENT ENGAGEMENT SOLUTIONS
                     TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS (%) FOR PATIENT ENGAGEMENT SOLUTIONS
           5.13.2 BUYING CRITERIA
                     FIGURE 32 KEY BUYING CRITERIA FOR PATIENT ENGAGEMENT SOLUTIONS
                     TABLE 13 KEY BUYING CRITERIA FOR PATIENT ENGAGEMENT SOLUTION COMPONENTS
    5.14 END USER ANALYSIS 
           5.14.1 UNMET NEEDS
                     TABLE 14 UNMET NEEDS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
           5.14.2 END USER EXPECTATIONS
                     TABLE 15 END USER EXPECTATIONS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
    5.15 KEY CONFERENCES & EVENTS IN 2023–2024 
            TABLE 16 PATIENT ENGAGEMENT SOLUTIONS: DETAILED LIST OF CONFERENCES & EVENTS
    5.16 REPLACEMENT TRENDS FOR PATIENT ENGAGEMENT SOLUTIONS 
    5.17 PATIENT ENGAGEMENT SOLUTIONS INVESTMENT LANDSCAPE 
            FIGURE 33 INVESTOR DEALS AND FUNDING IN PATIENT ENGAGEMENT SOLUTIONS SOARED IN 2022
            FIGURE 34 MOST VALUED PATIENT ENGAGEMENT SOLUTION FIRMS IN 2022 (USD BILLION)
    5.18 PATIENT ENGAGEMENT SOLUTIONS BUSINESS MODELS 
           5.18.1 SUBSCRIPTION-BASED MODEL
           5.18.2 LICENSING MODEL
           5.18.3 HYBRID MODEL
           5.18.4 FREEMIUM MODEL
           5.18.5 VALUE-BASED PRICING MODEL
           5.18.6 DATA MONETIZATION
           5.18.7 CUSTOM DEVELOPMENT/CONSULTING MODEL
           5.18.8 INTEGRATION WITH EXISTING SYSTEMS
           5.18.9 PARTNERSHIPS WITH HEALTHCARE PROVIDERS
                    5.18.10 WHITE-LABEL SOLUTIONS
                    5.18.11 OPEN-SOURCE SOFTWARE
    5.19 USE CASES/CASE STUDIES 
           5.19.1 FOCUS ON REDUCING READMISSION RATES AND IMPROVING CARE
                    5.19.1.1 Use case 1: Need to reduce patient hospital stays
           5.19.2 IMPROVE OUTPATIENT COMMUNICATION
                    5.19.2.1 Case 2: Rising need to curb miscommunication with discharged patients
           5.19.3 PATIENT ENGAGEMENT STRATEGY
                    5.19.3.1 Use case 3: Post-discharge care
           5.19.4 AN EMR-AGNOSTIC PATIENT ENGAGEMENT PLATFORM WITH COMPREHENSIVE BUILT-IN CAPABILITIES
                    5.19.4.1 Use case 4: To improve patient engagement, giving patients ability to access all their medical information in one place
 
6 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT (Page No. - 138)
    6.1 INTRODUCTION 
          TABLE 17 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
    6.2 HARDWARE 
           6.2.1 INTERACTIVE EXPERIENCE FOR PATIENTS & FAMILIES
                    TABLE 18 HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                    TABLE 19 HARDWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 20 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 21 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 22 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 23 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 24 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.2 IN-ROOM TELEVISIONS
                    6.2.2.1 Increase in adoption of in-room televisions by hospitals
                                 TABLE 25 IN-ROOM TELEVISIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 26 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 27 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 28 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 29 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 30 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR IN-ROOM TELEVISIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.3 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES
                    6.2.3.1 Integrated bedside terminals enhance patient experience
                                 TABLE 31 INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 32 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 33 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 34 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 35 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 36 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED BEDSIDE TERMINALS/ASSISTED DEVICES, BY COUNTRY, 2021–2028 (USD MILLION)
           6.2.4 TABLETS
                    6.2.4.1 Portability and cost-effectiveness of tablets support growth
                                 TABLE 37 TABLETS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 38 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 39 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 40 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 41 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 42 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TABLETS, BY COUNTRY, 2021–2028 (USD MILLION)
    6.3 SOFTWARE 
          TABLE 43 SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 44 SOFTWARE MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 45 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 46 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 47 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 48 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 49 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.1 STANDALONE SOFTWARE
                    6.3.1.1 Standalone software refers to traditional software installed in client systems
                                 TABLE 50 STANDALONE SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 51 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 52 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 53 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 54 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 55 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR STANDALONE SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
           6.3.2 INTEGRATED SOFTWARE
                    6.3.2.1 Reduction in time spent on data management to drive growth
                                 TABLE 56 INTEGRATED SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 57 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 58 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 59 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 60 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 61 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR INTEGRATED SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
    6.4 SERVICES 
          TABLE 62 SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
          TABLE 63 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 64 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 65 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 66 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 67 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
 
7 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE (Page No. - 163)
    7.1 INTRODUCTION 
          TABLE 68 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
    7.2 ON-PREMISE MODE 
           7.2.1 PATIENT DATA SAFETY AND COST BENEFITS TO DRIVE MARKET
                    TABLE 69 ON-PREMISE MODE MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 70 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 71 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 72 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 73 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 74 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE MODE, BY COUNTRY, 2021–2028 (USD MILLION)
    7.3 CLOUD-BASED/ WEB-BASED MODE 
           7.3.1 REGULATORY REQUIREMENTS DRIVE HEALTHCARE PROVIDERS TO ADOPT CLOUD-BASED SOLUTIONS
                    TABLE 75 CLOUD-BASED/WEB-BASED MODE MARKET, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 76 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 77 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 78 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 79 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 80 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD-BASED MODE, BY COUNTRY, 2021–2028 (USD MILLION)
 
8 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION (Page No. - 171)
    8.1 INTRODUCTION 
          TABLE 81 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
    8.2 HEALTH MANAGEMENT 
           8.2.1 HEALTH MANAGEMENT PLAYS CRUCIAL TOOL IN GUIDING PATIENTS IN SELF-CARE
                    TABLE 82 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 83 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 84 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 85 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 86 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 87 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
    8.3 HOME HEALTH MANAGEMENT 
           8.3.1 GROWING PREFERENCE FOR HOME HEALTHCARE TO SUPPORT MARKET GROWTH
                    TABLE 88 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 89 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 90 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 91 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 92 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 93 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
    8.4 SOCIAL & BEHAVIORAL MANAGEMENT 
           8.4.1 GROWING POPULARITY OF SOCIAL MEDIA TO DRIVE MARKET GROWTH
                    TABLE 94 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 95 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 96 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 97 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 98 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 99 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOCIAL & BEHAVIORAL MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
    8.5 FINANCIAL HEALTH MANAGEMENT 
           8.5.1 FINANCIAL ENGAGEMENT SOLUTIONS HELP PROVIDERS MANAGE PATIENT PAYMENTS
                    TABLE 100 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 101 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 102 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 103 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 104 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 105 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FINANCIAL HEALTH MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
 
9 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA (Page No. - 185)
    9.1 INTRODUCTION 
          TABLE 106 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
    9.2 CHRONIC DISEASES 
          TABLE 107 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY REGION, 2021–2028 (USD MILLION)
          TABLE 108 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY TYPE, 2021–2028 (USD MILLION)
          TABLE 109 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 110 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 111 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 112 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 113 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.1 CARDIOVASCULAR DISEASES (CVD)
                    9.2.1.1 Leading cause of death worldwide
                                 TABLE 114 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 115 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 116 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 117 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 118 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 119 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.2 DIABETES
                    9.2.2.1 High incidence of diabetes worldwide drives growth
                                 TABLE 120 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 121 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 122 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 123 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 124 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 125 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DIABETES, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.3 OBESITY
                    9.2.3.1 Rising prevalence of obesity to drive growth
                                 TABLE 126 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY REGION, 2021–2028 (USD MILLION)
                                 TABLE 127 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 128 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 129 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 130 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)
                                 TABLE 131 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OBESITY, BY COUNTRY, 2021–2028 (USD MILLION)
           9.2.4 OTHER CHRONIC DISEASES
                    TABLE 132 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 133 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 134 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 135 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 136 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 137 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER CHRONIC DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)
    9.3 WOMEN’S HEALTH 
           9.3.1 INCREASING SELF-AWARENESS FOR MANAGEMENT OF DISEASES TO DRIVE MARKET
                    TABLE 138 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 139 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 140 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 141 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 142 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 143 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR WOMEN’S HEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
    9.4 FITNESS 
           9.4.1 GROWING PREFERENCE FOR HEALTHY LIFESTYLE TO SUPPORT MARKET GROWTH
                    TABLE 144 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY REGION, 2021–2028 (USD MILLION)
                    TABLE 145 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 146 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 147 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 148 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)
                    TABLE 149 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR FITNESS, BY COUNTRY, 2021–2028 (USD MILLION)
    9.5 OTHER THERAPEUTIC AREAS 
          TABLE 150 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY REGION, 2021–2028 (USD MILLION)
          TABLE 151 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 152 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 153 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 154 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
          TABLE 155 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER THERAPEUTIC AREAS, BY COUNTRY, 2021–2028 (USD MILLION)
 
10 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY (Page No. - 211)
     10.1 INTRODUCTION 
             TABLE 156 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
     10.2 PATIENT/CLIENT SCHEDULING 
             10.2.1 STREAMLINING OF WORKFLOWS AND EFFICIENT MANAGEMENT OF PATIENT SCHEDULES
                        TABLE 157 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 158 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 159 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 160 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 161 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 162 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT/CLIENT SCHEDULING, BY COUNTRY, 2021–2028 (USD MILLION)
     10.3 TELEHEALTH 
             10.3.1 FLEXIBILITY IN TREATMENT OPTIONS DUE TO REMOTE MONITORING
                        TABLE 163 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 164 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 165 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 166 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 167 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 168 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR TELEHEALTH, BY COUNTRY, 2021–2028 (USD MILLION)
     10.4 E-PRESCRIBING 
             10.4.1 COST-EFFECTIVE METHOD TO ENHANCE DECISION-MAKING
                        TABLE 169 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 170 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 171 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 172 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 173 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 174 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR E-PRESCRIBING, BY COUNTRY, 2021–2028 (USD MILLION)
     10.5 DOCUMENT MANAGEMENT 
             10.5.1 EFFECTIVE MANAGEMENT OF PATIENT DOCUMENTS CRUCIAL FOR HEALTHCARE PROVIDERS
                        TABLE 175 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 176 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 177 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 178 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 179 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 180 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR DOCUMENT MANAGEMENT, BY COUNTRY, 2021–2028 (USD MILLION)
     10.6 BILLING & PAYMENTS 
             10.6.1 DEMAND FOR STREAMLINED PROCESSES TO DRIVE MARKET GROWTH
                        TABLE 181 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 182 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 183 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 184 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 185 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 186 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILLING & PAYMENTS, BY COUNTRY, 2021–2028 (USD MILLION)
     10.7 PATIENT EDUCATION 
             10.7.1 RISING DEMAND FOR INFORMED HEALTHCARE TO DRIVE MARKET GROWTH
                        TABLE 187 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 188 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 189 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 190 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 191 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 192 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENT EDUCATION, BY COUNTRY, 2021–2028 (USD MILLION)
     10.8 OTHER FUNCTIONALITIES 
             TABLE 193 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY REGION, 2021–2028 (USD MILLION)
             TABLE 194 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 195 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 196 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 197 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 198 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER FUNCTIONALITIES, BY COUNTRY, 2021–2028 (USD MILLION)
 
11 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER (Page No. - 234)
     11.1 INTRODUCTION 
             TABLE 199 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
     11.2 PROVIDERS 
             11.2.1 LARGEST END USERS OF PATIENT ENGAGEMENT SOLUTIONS
                        TABLE 200 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 201 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 202 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 203 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 204 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 205 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 206 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
             11.2.2 HOSPITALS & HEALTHCARE SYSTEMS
                        11.2.2.1 Hospitals and healthcare systems contribute highest share
                                      TABLE 207 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY REGION, 2021–2028 (USD MILLION)
                                      TABLE 208 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 209 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 210 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 211 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 212 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOSPITALS & HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
             11.2.3 AMBULATORY CARE CENTERS
                        11.2.3.1 Gradual shift of patient care from inpatient to outpatient settings to drive growth
                                      TABLE 213 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
                                      TABLE 214 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 215 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 216 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 217 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 218 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
             11.2.4 HOME CARE CENTERS
                        11.2.4.1 Rise in global geriatric population requiring long-term care to support market growth
                                      TABLE 219 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY REGION, 2021–2028 (USD MILLION)
                                      TABLE 220 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 221 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 222 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 223 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 224 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HOME CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
             11.2.5 OTHER PROVIDERS
                        TABLE 225 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 226 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 227 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 228 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 229 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 230 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER PROVIDERS, BY COUNTRY, 2021–2028 (USD MILLION)
     11.3 PAYERS 
             11.3.1 PATIENT ENGAGEMENT SOLUTIONS HELP HEALTHCARE PAYERS MINIMIZE ERRORS
                        TABLE 231 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 232 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 233 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 234 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 235 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 236 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 237 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
             11.3.2 PRIVATE
                        11.3.2.1 Private payers partnering with telehealth vendors for seamless healthcare solutions
                                      TABLE 238 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY REGION, 2021–2028 (USD MILLION)
                                      TABLE 239 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 240 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 241 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 242 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 243 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PRIVATE PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
             11.3.3 PUBLIC
                        11.3.3.1 Investments made by public payers to support market
                                      TABLE 244 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY REGION, 2021–2028 (USD MILLION)
                                      TABLE 245 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 246 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 247 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 248 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
                                      TABLE 249 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PUBLIC PAYERS, BY COUNTRY, 2021–2028 (USD MILLION)
     11.4 PATIENTS 
             11.4.1 PATIENT ENGAGEMENT SOLUTIONS MOTIVATE INDIVIDUALS TO MONITOR AND IMPROVE HEALTH OUTCOMES
                        TABLE 250 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2021–2028 (USD MILLION)
                        TABLE 251 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 252 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 253 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 254 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 255 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY, 2021–2028 (USD MILLION)
     11.5 OTHER END USERS 
             TABLE 256 PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
             TABLE 257 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 258 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 259 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 260 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
             TABLE 261 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
 
12 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION (Page No. - 266)
     12.1 INTRODUCTION 
             TABLE 262 PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
     12.2 NORTH AMERICA 
             FIGURE 35 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
             12.2.1 RECESSION IMPACT
                        TABLE 263 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 264 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 265 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 266 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 267 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 268 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 269 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 270 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 271 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 272 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 273 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 274 NORTH AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.2.2 US
                        12.2.2.1 High healthcare expenditure and affordable costs to drive market
                                      TABLE 275 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 276 US: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 277 US: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 278 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 279 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 280 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 281 US: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 282 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 283 US: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 284 US: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 285 US: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.2.3 CANADA
                        12.2.3.1 Growing need for cost containment to drive market
                                      TABLE 286 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 287 CANADA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 288 CANADA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 289 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 290 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 291 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 292 CANADA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 293 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 294 CANADA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 295 CANADA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 296 CANADA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
     12.3 EUROPE 
             12.3.1 RECESSION IMPACT
                        TABLE 297 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 298 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 299 EUROPE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 300 EUROPE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 301 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 302 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 303 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 304 EUROPE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 305 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 306 EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 307 EUROPE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 308 EUROPE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.2 GERMANY
                        12.3.2.1 Growing demand for effective patient records management to drive market
                                      TABLE 309 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 310 GERMANY: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 311 GERMANY: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 312 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 313 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 314 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 315 GERMANY: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 316 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 317 GERMANY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 318 GERMANY: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 319 GERMANY: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.3 FRANCE
                        12.3.3.1 Digital health insurance startups to drive market
                                      TABLE 320 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 321 FRANCE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 322 FRANCE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 323 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 324 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 325 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 326 FRANCE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 327 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 328 FRANCE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 329 FRANCE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 330 FRANCE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.4 UK
                        12.3.4.1 Favorable government initiatives promoting healthcare to drive market
                                      TABLE 331 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 332 UK: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 333 UK: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 334 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 335 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 336 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 337 UK: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 338 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 339 UK: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 340 UK: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 341 UK: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.5 SPAIN
                        12.3.5.1 Enhanced ability for monitoring patients and chronic illnesses to drive market
                                      TABLE 342 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 343 SPAIN: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 344 SPAIN: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 345 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 346 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 347 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 348 SPAIN: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 349 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 350 SPAIN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 351 SPAIN: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 352 SPAIN: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.6 ITALY
                        12.3.6.1 Growing burden of chronic diseases and shortage of healthcare workers to drive market
                                      TABLE 353 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 354 ITALY: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 355 ITALY: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 356 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 357 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 358 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 359 ITALY: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 360 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 361 ITALY: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 362 ITALY: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 363 ITALY: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.3.7 REST OF EUROPE
                        TABLE 364 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 365 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 366 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 367 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 368 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 369 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 370 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 371 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 372 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 373 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 374 REST OF EUROPE: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
     12.4 ASIA PACIFIC 
             12.4.1 RECESSION IMPACT
                        FIGURE 36 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET SNAPSHOT
                        TABLE 375 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 376 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 377 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 378 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 379 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 380 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 381 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 382 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 383 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 384 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 385 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 386 ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.2 JAPAN
                        12.4.2.1 Rising geriatric population to drive market
                                      TABLE 387 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 388 JAPAN: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 389 JAPAN: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 390 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 391 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 392 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 393 JAPAN: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 394 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 395 JAPAN: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 396 JAPAN: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 397 JAPAN: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.3 CHINA
                        12.4.3.1 Implementation of EMR solutions by government to drive market
                                      TABLE 398 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 399 CHINA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 400 CHINA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 401 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 402 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 403 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 404 CHINA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 405 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 406 CHINA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 407 CHINA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 408 CHINA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.4 INDIA
                        12.4.4.1 High burden of chronic diseases to drive market
                                      TABLE 409 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 410 INDIA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 411 INDIA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 412 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 413 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 414 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 415 INDIA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 416 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 417 INDIA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 418 INDIA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 419 INDIA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.4.5 REST OF ASIA PACIFIC
                        TABLE 420 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 421 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 422 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 423 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 424 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 425 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 426 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 427 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 428 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 429 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 430 REST OF ASIA PACIFIC: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
     12.5 LATIN AMERICA 
             12.5.1 RECESSION IMPACT
                        TABLE 431 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 432 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 433 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 434 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 435 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 436 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 437 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 438 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 439 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 440 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 441 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 442 LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.5.2 BRAZIL
                        12.5.2.1 Growing emphasis on reducing healthcare costs to drive market
                                      TABLE 443 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 444 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 445 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 446 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 447 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 448 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 449 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 450 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 451 BRAZIL: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 452 BRAZIL: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 453 BRAZIL: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.5.3 MEXICO
                        12.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market
                                      TABLE 454 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 455 MEXICO: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 456 MEXICO: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 457 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 458 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 459 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 460 MEXICO: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 461 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 462 MEXICO: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 463 MEXICO: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 464 MEXICO: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.5.4 REST OF LATIN AMERICA
                        TABLE 465 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 466 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 467 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 468 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 469 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 470 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 471 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 472 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 473 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 474 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 475 REST OF LATIN AMERICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
     12.6 MIDDLE EAST & AFRICA 
             12.6.1 RECESSION IMPACT
                        TABLE 476 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
                        TABLE 477 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 478 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 479 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 480 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 481 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 482 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 483 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 484 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 485 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 486 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 487 MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.6.2 GCC COUNTRIES
                        12.6.2.1 Initiatives for improving present health infrastructure to drive market
                                      TABLE 488 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                                      TABLE 489 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 490 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 491 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                                      TABLE 492 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                                      TABLE 493 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                                      TABLE 494 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 495 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                                      TABLE 496 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                                      TABLE 497 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                                      TABLE 498 GCC COUNTRIES: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
             12.6.3 REST OF MIDDLE EAST & AFRICA
                        TABLE 499 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2021–2028 (USD MILLION)
                        TABLE 500 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS HARDWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 501 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS SOFTWARE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 502 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE, 2021–2028 (USD MILLION)
                        TABLE 503 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
                        TABLE 504 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA, 2021–2028 (USD MILLION)
                        TABLE 505 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS CHRONIC DISEASE MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 506 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2021–2028 (USD MILLION)
                        TABLE 507 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2021–2028 (USD MILLION)
                        TABLE 508 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PROVIDERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
                        TABLE 509 REST OF MIDDLE EAST & AFRICA: PATIENT ENGAGEMENT SOLUTION PAYERS MARKET, BY TYPE, 2021–2028 (USD MILLION)
 
13 COMPETITIVE LANDSCAPE (Page No. - 382)
     13.1 OVERVIEW 
     13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 
             TABLE 510 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
     13.3 REVENUE ANALYSIS 
             FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT ENGAGEMENT SOLUTIONS MARKET
     13.4 MARKET SHARE ANALYSIS 
             FIGURE 38 PATIENT ENGAGEMENT SOLUTIONS MARKET: MARKET SHARE ANALYSIS (2022)
             TABLE 511 PATIENT ENGAGEMENT SOLUTIONS MARKET: DEGREE OF COMPETITION
             FIGURE 39 PATIENT ENGAGEMENT SOLUTIONS MARKET: RANKING OF KEY COMPANIES (2022)
     13.5 COMPANY EVALUATION MATRIX 
             13.5.1 STARS
             13.5.2 EMERGING LEADERS
             13.5.3 PERVASIVE PLAYERS
             13.5.4 PARTICIPANTS
                        FIGURE 40 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPANY EVALUATION MATRIX, 2022
             13.5.5 COMPANY FOOTPRINT
                        TABLE 512 COMPANY FOOTPRINT (14 COMPANIES)
                        TABLE 513 COMPONENT FOOTPRINT (14 COMPANIES)
                        TABLE 514 APPLICATION FOOTPRINT (14 COMPANIES)
                        TABLE 515 REGIONAL FOOTPRINT (14 COMPANIES)
     13.6 START-UP/SME EVALUATION MATRIX 
             13.6.1 PROGRESSIVE COMPANIES
             13.6.2 DYNAMIC COMPANIES
             13.6.3 RESPONSIVE COMPANIES
             13.6.4 STARTING BLOCKS
                        FIGURE 41 PATIENT ENGAGEMENT SOLUTIONS MARKET: STARTUP/SME EVALUATION MATRIX (2022)
             13.6.5 COMPETITIVE BENCHMARKING
                        TABLE 516 PATIENT ENGAGEMENT SOLUTIONS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
                        TABLE 517 PATIENT ENGAGEMENT SOLUTIONS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS (STARTUPS/SMES)
     13.7 COMPETITIVE SITUATIONS AND TRENDS 
             13.7.1 PRODUCT LAUNCHES/ENHANCEMENT
                        TABLE 518 PRODUCT LAUNCHES/ENHANCEMENT, 2020–2023
             13.7.2 DEALS
                        TABLE 519 DEALS, 2020–2023
             13.7.3 OTHER DEVELOPMENTS
                        TABLE 520 OTHER DEVELOPMENTS, (2020–2023)
 
14 COMPANY PROFILES (Page No. - 402)
     14.1 KEY PLAYERS 
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
             14.1.1 MCKESSON CORPORATION
                        TABLE 521 MCKESSON CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 MCKESSON CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 522 MCKESSON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 523 MCKESSON CORPORATION: PRODUCT LAUNCHES
                        TABLE 524 MCKESSON CORPORATION: DEALS
                        TABLE 525 MCKESSON CORPORATION: OTHER DEVELOPMENTS
             14.1.2 ORACLE CORPORATION
                        TABLE 526 ORACLE CORPORATION: COMPANY OVERVIEW
                        FIGURE 43 ORACLE CORPORATION: COMPANY SNAPSHOT (2023)
                        TABLE 527 ORACLE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 528 ORACLE CORPORATION: PRODUCT DEVELOPMENTS
                        TABLE 529 ORACLE CORPORATION: DEALS
             14.1.3 VERADIGM LLC
                        TABLE 530 VERADIGM LLC: COMPANY OVERVIEW
                        FIGURE 44 VERADIGM LLC: COMPANY SNAPSHOT (2021)
                        TABLE 531 VERADIGM LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 532 VERADIGM LLC: PRODUCT LAUNCHES
                        TABLE 533 VERADIGM LLC: DEALS
                        TABLE 534 VERADIGM LLC: OTHER DEVELOPMENTS
             14.1.4 ATHENAHEALTH
                        TABLE 535 ATHENAHEALTH: COMPANY OVERVIEW
                        TABLE 536 ATHENAHEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 537 ATHENAHEALTH: PRODUCT ENHANCEMENT
                        TABLE 538 ATHENAHEALTH: DEALS
                        TABLE 539 ATHENAHEALTH: OTHER DEVELOPMENTS
             14.1.5 ORION HEALTH
                        TABLE 540 ORION HEALTH: COMPANY OVERVIEW
                        TABLE 541 ORION HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 542 ORION HEALTH: PRODUCT LAUNCHES
                        TABLE 543 ORION HEALTH: DEALS
                        TABLE 544 ORION HEALTH: OTHER DEVELOPMENTS
             14.1.6 GETWELLNETWORK, INC.
                        TABLE 545 GETWELLNETWORK, INC.: COMPANY OVERVIEW
                        TABLE 546 GETWELLNETWORK, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 547 GETWELLNETWORK, INC.: PRODUCT LAUNCHES
                        TABLE 548 GETWELLNETWORK, INC.: DEALS
                        TABLE 549 GETWELLNETWORK, INC.: OTHER DEVELOPMENTS
             14.1.7 LINCOR INC.
                        TABLE 550 LINCOR INC.: COMPANY OVERVIEW
                        TABLE 551 LINCOR INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 552 LINCOR INC.: OTHER DEVELOPMENTS
             14.1.8 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
                        TABLE 553 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY OVERVIEW
                        FIGURE 45 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: COMPANY SNAPSHOT (2022)
                        TABLE 554 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
                        TABLE 555 COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION: OTHER DEVELOPMENTS
             14.1.9 GET REAL HEALTH
                        TABLE 556 GET REAL HEALTH: COMPANY OVERVIEW
                        TABLE 557 GET REAL HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 558 GET REAL HEALTH: PRODUCT LAUNCHES
                        TABLE 559 GET REAL HEALTH: OTHER DEVELOPMENTS
             14.1.10 ONEVIEW HEALTHCARE
                        TABLE 560 ONEVIEW HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 46 ONEVIEW HEALTHCARE: COMPANY SNAPSHOT (2022)
                        TABLE 561 ONEVIEW HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 562 ONEVIEW HEALTHCARE: PRODUCT LAUNCH/ENHANCEMENT
                        TABLE 563 ONEVIEW HEALTHCARE: DEALS
                        TABLE 564 ONEVIEW HEALTHCARE: OTHER DEVELOPMENTS
             14.1.11 ADVANCEDMD, INC.
                        TABLE 565 ADVANCEDMD, INC.: COMPANY OVERVIEW
                        TABLE 566 ADVANCEDMD, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
             14.1.12 EPIC SYSTEMS CORPORATION
                        TABLE 567 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
                        TABLE 568 EPIC SYSTEMS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 569 EPIC SYSTEMS CORPORATION: DEALS
             14.1.13 HARRIS HEALTHCARE
                        TABLE 570 HARRIS HEALTHCARE: COMPANY OVERVIEW
                        TABLE 571 HARRIS HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 572 HARRIS HEALTHCARE: DEALS
                        TABLE 573 HARRIS HEALTHCARE: OTHER DEVELOPMENTS
             14.1.14 MEDICAL INFORMATION TECHNOLOGY, INC.
                        TABLE 574 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
                        TABLE 575 MEDICAL INFORMATION TECHNOLOGY, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
                        TABLE 576 MEDICAL INFORMATION TECHNOLOGY, INC.: DEALS
                        TABLE 577 MEDICAL INFORMATION TECHNOLOGY, INC.: OTHER DEVELOPMENTS
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
     14.2 OTHER PLAYERS 
             14.2.1 KAREO, INC.
             14.2.2 ECLINICAL WORKS
             14.2.3 WELLSTACK
             14.2.4 IQVIA HOLDINGS INC.
             14.2.5 VIVIFY HEALTH
             14.2.6 MEDHOST
             14.2.7 LUMA HEALTH
             14.2.8 CUREMD HEALTHCARE
             14.2.9 SONIFI HEALTH
             14.2.10 ADVANTECH CO., LTD.
             14.2.11 BARCO
 
15 APPENDIX (Page No. - 454)
     15.1 DISCUSSION GUIDE 
     15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     15.3 CUSTOMIZATION OPTIONS 
     15.4 RELATED REPORTS 
     15.5 AUTHOR DETAILS 

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Patient Engagement Solutions market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the patient engagement solutions market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global patient engagement solutions market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global patient engagement solutions market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

A breakdown of the primary respondents is provided below:

Patient Engagement Solutions Market Size, and Share

Note: The tier of companies is defined based on their total revenues. As of 2022, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

Note 2: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 3: Other primaries include sales managers, marketing managers, and product managers.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME

DESIGNATION

Oracle Corporation

Product Manager

Veradigm

Director

Merative

Senior Product Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the global patient engagement solutions market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of patient engagement solutions products by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Market Size Estimation- Top-Down Approach

Patient Engagement Solutions Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Market Size Estimation- Bottom-Up Approach

Patient Engagement Solutions Market Size, and Share

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the patient engagement solutions market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

Market Definition

Patient engagement is a key component of value-based healthcare, which focuses on improving the quality of care while reducing costs. It combines the patient’s knowledge, skills, ability, and willingness to manage individual health with the help of engagement solutions to increase activation & promote positive patient behavior. Patient Engagement solutions promote effective care coordination by facilitating seamless communication between patients and healthcare providers.

Key Stakeholders

  • Healthcare institutes/providers (hospitals, medical groups, physician practices, diagnostic centers, pharmacies, ambulatory centers, and outpatient clinics)
  • Healthcare insurance companies/payers
  • Healthcare IT service providers
  • Venture capitalists
  • Government bodies
  • Corporate healthcare entities
  • Accountable care organizations

Report Objectives

  • To define, describe, and forecast the global patient engagement solutions market based on component, delivery mode, application, therapeutic area, functionality, end user, and region
  • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall patient engagement solutions market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To strategically analyze the market structure and profile the key players of the patient engagement solutions market and comprehensively analyze their core competencies
  • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa.
  • To track and analyze competitive developments such as product launches, acquisitions, partnerships, agreements, and collaborations in the patient engagement solutions market during the forecast period

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company information

  • Detailed analysis and profiling of additional market players (up to 20)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 2767
Published ON
Dec, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Patient Engagement Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback